Aurora Cannabis has shifted focus to the medical cannabis market, achieving higher gross margins. Read why I upgrade ACB ...
Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis ...
Aurora Cannabis Inc (ACB) reports a robust quarter with significant increases in global medical cannabis revenue and a ...
Shares of Aurora Cannabis Inc. ACB rose 6.36% to $3.68 Tuesday, on what proved to be an all-around positive trading session ...
Aurora Cannabis (ACB) stock surges 27% in premarket after reporting strong Q3 fiscal 2025 results with record-breaking ...
Aurora Cannabis’ short interest ratio sits at 5.2. This tells us that short interest on the stock is relatively high. It also ...
Operator Greetings, and welcome to the Aurora Cannabis Inc. third quarter 2025 results conference call. [Operator ...
Basic bullish pattern shows that Aurora Cannabis formed a bullish setup with an impulsive five-wave rally, followed by an ABC ...
Aurora Cannabis (NASDAQ: ACB) surged 45% after reporting record earnings, boosting CGC, TLRY, and CRON stocks.
Aurora Cannabis posted Q3 FY25 net revenue of CA$88.2 million, driven by medical cannabis and plant propagation growth, with ...
Canaccord raised the firm’s price target on Aurora Cannabis (ACB) to C$12.50 from C$10 and keeps a Buy rating on the shares.Maximize Your ...
TD Securities raised the firm’s price target on Aurora Cannabis (ACB) to C$10 from C$9 and keeps a Buy rating on the shares.Maximize Your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results